A preview of this full-text is provided by American Psychological Association.
Content available from Families Systems & Health
This content is subject to copyright. Terms and conditions apply.
Treatment Barriers in PANS/PANDAS: Observations From Eleven
Health Care Provider Families
Angela W. Tang, MD
1
, Heidi J. Appel, MD
2
, Stacie C. Bennett, MD
3
,
Leighann H. Forsyth, PhD
4
, Susan K. Glasser, MD
5
, Maura A. Jarka, RN, APN
6
,
Pierre D. Kory, MD
7
, Amy N. Malik, MD
8
, Andrea I. Martonoffy, MD
9
,
Lena K. Wahlin, MD
10
, Tricia T. Williams, MD
11
, Nate A. Woodin, LMFT
12
,
Lien C. Woodin, BSN
13
,IanK.T.Miller
14
, and Loren G. Miller, MD, MPH
15
1
Healthcare Partners Medical Group, Torrance, California, United States
2
Medstar Georgetown University Medical Center
3
Division of Neonatology, Children's Hospital of Oakland
4
Psychiatry, Case Western Reserve University
5
Department of Pediatrics, University of Connecticut
6
Cardiac Surgery Associates, Downers Grove, Illinois, United States
7
Aurora Health Care, Milwaukee, Wisconsin, United States
8
Division of Pulmonary and Critical Care Medicine, University of Wisconsin
9
Department of Family Medicine and Community Health, University of Wisconsin
10
Private Practice, Emergency and Intensive Care Medicine, Visby, Sweden
11
Endless Mountain Integrative Medicine, Troy, Pennsylvania, United States
12
Private Practice, Marriage and Family Therapy Portland, Maine, United States
13
Private Practice, Critical Care Nursing Portland, Maine, United States
14
Palos Verdes Peninsula High School, Rolling Hill Estates, California
15
Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical
Center, Torrance, California
Introduction: Pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric
autoimmune neuropsychiatric disorder associated with streptococcal infections
(PANDAS) are severe but highly treatable postinfectious inflammatory brain
conditions. Despite published diagnostic and treatment guidelines for this condition,
there are long delays in obtaining appropriate care. The reasons for these delays are
poorly understood. We sought to identify health care system barriers to timely
treatment by examining cases of PANDAS/PANS occurring in children of health care
professionals. Method: We recruited families via e-mail request through the PANDAS
Physicians Network. Participating parents completed a structured questionnaire and
provided a written case description. Results: Eleven families completed data
collection, representing a broad spectrum of disease (child disease onset age 4–15, 7
males/4 females, mild to severe). Parents included 11 physicians, 2 mental health
This article was published Online First October 7, 2021.
Tricia T. Williams, MD https://orcid.org/0000-0001-
5706-0897
Loren G. Miller, MD, MPH https://orcid.org/0000-
0003-0487-1711
None of the authors received any funding related to the
content of the manuscript.
Angela W. Tang and Loren G. Miller contributed to study
conception, data collection, data analysis, and manuscript
preparation. Ian K. T. Miller contributed to data analysis, and
manuscript preparation. The remaining authors contributed to
data collection, data analysis, and manuscript preparation.
Correspondence concerning this article should be
addressed to Loren G. Miller, MD, MPH, 1124 West
Carson Street, Box 466, Torrance, CA 90502, United
States. Email: lgmiller@ucla.edu
477
Families, Systems, & Health
©2021 American Psychological Association 2021, Vol. 39, No. 3, 477–487
ISSN: 1939-0602 https://doi.org/10.1037/fsh0000602
This document is copyrighted by the AmericanPsychological Association or one of its allied publishers.
This article is intended solely for the personaluse of the individual user and is not to be disseminated broadly.